Fund II (2004)

Acclarent

Acclarent® is the leader in the field of minimally invasive treatments for Ear Nose and Throat (ENT) conditions including sinusitis and airway stenosis.  Acclarent pioneered the field of Balloon Sinuplasty as a treatment for chronic sinusitis, a problem impacting over 35 million people each year, making it one of the most common health problems in the United States. Acclarent was acquired in 2010 and is now a division of Johnson and Johnson.